MedTrace Logo

Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns

NCT07425028 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2026-05-22

No results posted yet for this study

Summary

Currently in France, screening for congenital hypothyroidism (CH) in premature infants is done by a single TSH assay on filter paper. However, European recommendations advise repeating the assay within the first month of life.

Our primary objective is to estimate the incidence of CH in preterm infants under 32 weeks of gestational age by applying the European recommendations.

Conditions

  • Congenital Hypothyroidism

Interventions

BIOLOGICAL

Blood test

routine care blood draw

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Christine LEFEVRE, MD · University Hospital, Lille

  • Anais GLUSKO-CHARLET, MD · Arras Hospital Center

  • Sylvie MARIETTE, MD · Roubaix Hospital Center

  • Pierre TOURNEUX, MD · Amiens University Hospital

Eligibility

Min Age
23 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-03-31
Primary Completion
2028-03-31
Completion
2028-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07425028 on ClinicalTrials.gov